1-3 of 3
Veerle Gillijns
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor

Simon F. De Meyer, Karen Vanhoorelbeke, Marinee K. Chuah, Inge Pareyn, Veerle Gillijns, Robert P. Hebbel, Désiré Collen, Hans Deckmyn, Thierry VandenDriessche
Journal: Blood
Blood (2006) 107 (12): 4728–4736.
https://doi.org/10.1182/blood-2005-09-3605
Published: 2006
Journal Articles

Phenotypic Correction of von Willebrand Disease Type 3 Blood-Derived Endothelial Cells with Lentiviral Vectors Expressing von Willebrand Factor.

Simon F. De Meyer, Karen Vanhoorelbeke, PhD, Marinee K. Chuah, PhD, Inge Pareyn, Veerle Gillijns, Robert P. Hebbel, MD, Hans Deckmyn, PhD, Thierry Vandendriessche, PhD
Journal: Blood
Blood (2005) 106 (11): 5522.
https://doi.org/10.1182/blood.V106.11.5522.5522
Published: 2005
Journal Articles

Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors

Marinee K. L. Chuah, Gudrun Schiedner, Lieven Thorrez, Brian Brown, Marion Johnston, Veerle Gillijns, Sabine Hertel, Nico Van Rooijen, David Lillicrap, Désiré Collen, Thierry VandenDriessche, Stefan Kochanek
Journal: Blood
Blood (2003) 101 (5): 1734–1743.
https://doi.org/10.1182/blood-2002-03-0823
Published: 2003